<DOC>
	<DOCNO>NCT02269540</DOCNO>
	<brief_summary>The investigator look MAO-A density seven week treatment antidepressant dietary supplement . MAO-A enzyme break brain chemical regulate mood . MAO-A density elevate patient major depressive episode ( MDE ) secondary major depressive disorder ( MDD ) . Many remain treatment resistant common antidepressant treatment think may due poor target brain pathology . We want test add dietary supplement may normalize MAO-A .</brief_summary>
	<brief_title>A New Treatment Approach Major Depressive Disorder Based Upon Targeting Monoamine Oxidase A ( MAO-A )</brief_title>
	<detailed_description>All subject get combine treatment selective serotonin reuptake inhibitor dietary supplement . There two possible selective serotonin reuptake inhibitor treatment dietary supplement remain . No subject receive selective serotonin reuptake inhibitor alone subject receive dietary supplement alone . The dietary supplement call n-acetylcysteine .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Citalopram</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<mesh_term>Serotonin Uptake Inhibitors</mesh_term>
	<mesh_term>Dexetimide</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>DSMIV diagnosis current major depressive episode major depressive disorder Hamilton Depression Rating Scale score least 20 Comorbid axis I II disorder Antidepressant use past 6 month Current use herbal remedy Cigarette smoke Drug medication use within past 8 week History substance abuse/neurotoxin use History psychotic symptom History CNS medical illness Current substance use Test positive pregnancy test ( woman )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>49 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>